This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
ETFs to Buy on UnitedHealth's Q2 Earnings Beat
by Sweta Killa
UnitedHealth reported better-than-expected second-quarter 2022 results, breezing past the Zacks Consensus Estimate for both earnings and revenues. The company lifted its full-year earnings guidance for the second straight quarter.
Healthcare ETFs to Gain on UnitedHealth's Solid Q1 Earnings
by Sweta Killa
UnitedHealth reported better-than-expected first-quarter 2020 results, breezing past the Zacks Consensus Estimate for both earnings and revenues. The company lifted its full-year earnings guidance.
UnitedHealth's Solid Q4 Earnings Put These ETFs in Focus
by Sweta Killa
Investors could tap this opportune moment with ETFs having the largest allocation to UnitedHealth.
UnitedHealth's Solid Q2 Earnings Put These ETFs in Focus
by Sweta Killa
UnitedHealth reported better-than-expected second-quarter 2021 results, breezing past the Zacks Consensus Estimate for both earnings and revenues.
Are Healthcare ETFs Poised for a Comeback?
by Sanghamitra Saha
Decent earnings growth picture and valuation as well as solid deals activities have been favoring healthcare sector at the current level.
Healthcare ETFs to Gain on UnitedHealth's Strong Q1 Earnings
by Sweta Killa
UnitedHealth Group (UNH) reported better-than-expected first-quarter 2021 results wherein it breezed past the Zacks Consensus Estimate on both earnings and revenues. It also lifted its full-year earnings outlook.
5 ETFs to Make the Most of Thermo Fisher Deal to Buy PPD
by Sweta Killa
Thermo Fisher Scientific (TMO) has agreed to buy the healthcare testing company PPD Inc. (PPD) for $17.4 billion in cash.
Healthcare ETFs in Focus on UnitedHealth's Solid Q4 Earnings
by Sweta Killa
UnitedHealth Group (UNH) reported better-than-expected fourth-quarter 2020 results wherein it breezed past the Zacks Consensus Estimate on both earnings and revenues.
ETFs to Gain on UnitedHealth and Change Healthcare Deal
by Sweta Killa
UnitedHealth agreed to buy Change Healthcare for $7.84 billion in cash.
UnitedHealth Q3 Solid Result Put Healthcare ETFs in Focus
by Sweta Killa
UnitedHealth reported better-than-expected third-quarter 2020 results wherein it breezed past the Zacks Consensus Estimate on both earnings and revenues. It also lifted its full year outlook.
UnitedHealth Beats: Healthcare ETFs in Focus
by Sweta Killa
UnitedHealth Group reported stronger-than-expected second-quarter 2020 results wherein it breezed past the Zacks Consensus Estimate on both earnings and revenues.
Healthcare ETFs in Focus Post UnitedHealth's Q1 Earnings
by Sweta Killa
UnitedHealth reported mixed first-quarter 2020 results wherein it breezed past the Zacks Consensus Estimate on earnings but lagged the same for revenues.
Healthcare ETFs in Focus on UnitedHealth's Q4 Earnings
by Sweta Killa
UnitedHealth Group reported mixed fourth-quarter 2019 results wherein it breezed past the Zacks Consensus Estimate on earnings but lagged on revenues.
Healthcare ETFs to Buy on UnitedHealth's Solid Q3 Earnings
by Sweta Killa
Investors could tap the company's strong growth story with ETFs having the largest allocation to this health insurance giant.
Healthcare ETFs in Focus on UnitedHealth's Q2 Earnings
by Sweta Killa
ETFs having the largest allocation to this health insurance giant are in focus post Q2 earnings.
ETFs to Shine as Trump Tosses Drug Rebate Curb Plan
by Sweta Jaiswal, FRM
We study the impact of Trump's dropping of the proposed drug rebate rule on some health ETFs with exposure to pharmacy benefit managers and healthcare insurers.
UnitedHealth Falls Despite Q1 Beat, Healthcare ETFs in Focus
by Sweta Killa
UnitedHealth Group reported robust first-quarter 2019 results. The company breezed past the Zacks Consensus Estimate on both earnings and revenues and raised its full-year forecast.
UnitedHealth Pops on Solid Q4: Healthcare ETFs to Buy
by Sweta Killa
ETFs having the largest allocation to UnitedHealth has been in focus post its solid result.
8 Top Active ETFs of 2018
by Sanghamitra Saha
Inside the top-performing active ETFs of 2018.
Fed Hikes Rates as Expected: ETF Areas That Gained
by Sanghamitra Saha
The Fed hikes rates as expected and there was no wild movement in the market. These ETF areas ended in the green post hike.
Healthcare ETFs to Ride on UnitedHealth's Solid Q2 & Outlook
by Sweta Killa
Investors should tap the opportunity with ETFs having the largest allocation to UnitedHealth.